Mepilex Lite - Clinically proven to work

Mepilex Lite - Clinically proven to work

About 900,000 women are diagnosed with breast cancer yearly, according to the World Health Organization, (WHO). Erythema occurs in 80-90% of women treated for breast cancer with radiation therapy. Currently, there is no standard treatment for radiation-induced skin reactions. This study is the first to prove a clinically effective treatment that would make life a lot easier for women with breast cancer undergoing radiation therapy.

Share this

방사선 치료로 인한 피부 반응

Radiation-induced skin reactions can be graded according to the Radiotherapy Oncology Group Assessment tool(RTOG); clinical guidelines recommended by the College of Radiographers;